CDC疫苗小组一致投票改变COVID-19疫苗推荐

2025-09-20 03:00

The CDC's Advisory Committee on Immunization Practices voted 12-0 Friday afternoon to recommend changes to who is eligible for COVID-19 shots.
The recommendation mirrors the authorization the US FDA gave to the Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX), and Novavax (NASDAQ:NVAX) shots in late August.
As adopted, the recommendation is for vaccinating for adults 65 years and older "based on individual-based decision-making." For those six months to 64 years old, it is also based on the same decision-making "with an emphasis that the risk-benefit of vaccination is most favorable to individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk..."
During debate, it was clarified that getting a COVID shot can be done -- as in the past -- by pharmacists.
The vote is not binding and a final decision will be made by acting CDC director Jim O'Neill, who is also deputy secretary at HHS, making him close to HHS Secretary Robert F. Kennedy Jr.
Dear Readers: We recognize that politics often intersect with the financial news of the day, so we invite you to click here to join the separate political discussion.
This is breaking news and will be updated...

More on Moderna, Pfizer